뒤로
Immuron Limited (IMRN) 주가 예측
IMRN 주가 차트
IMRN 주가 예측
Immuron Limited
$0.7
-0.42%
$0
종가: Mar 23, 16:00:00 GMT-4
$0.7
0%
$0
애프터마켓: Mar 23, 20:00:00 GMT-4
주요 통계
이전 종가
$0.703
시가
$0.7
일일 범위
$0.7 - $0.7001
52주 범위
$0.677 - $2.39
거래량
10.5K
평균 거래량
44.7K
배당수익률
--
EPS(TTM)
-0.52
시가총액
$5.7M
Immuron Limited란 무엇인가요?
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.